Floatz logo

compound solution of sodium chloride

Blood Loss, Surgical

SangartmixturePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Blood Loss, Surgical cohort.

Asset / SponsorPhaseRating
Tranexamic Acid
University of Virginia
Phase 4BB
Hemospan
Sangart
Phase 2B

Same molecule, other indications

compound solution of sodium chloride is also rated in:

hemorrhagic strokeDormant
B
Indicative ·
62 / 100
View asset →
infectious disease with sepsisDormant
B
Indicative ·
61 / 100
View asset →
SurgeryDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →